News
-
-
-
-
-
PRESS RELEASE
Protagonist Announces Presentations of Clinical Data with Icotrokinra in Plaque Psoriasis and Preclinical Data with PN-881 at the EADV 2025 Congress
Protagonist Therapeutics announces superior skin clearance data for icotrokinra compared to deucravacitinib and sustained clearance in ICONIC-LEAD study. Preclinical data on PN-881 presented at EADV Congress 2025 -
-
-
-
-